L

Lord Winston (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Puberty Blockers and Cross-sex Hormones

Contribution

My Lords, it is always a pleasure to speak after the noble Baroness, Lady Deech, even when I disagree with her. Unfortunately, that happens all the time, much to my embarrassment. Like her, I greatly welcome the noble Baroness, Lady Cass, to speak on this subject, on which she is so expert. Unlike the noble Baroness, Lady Deech, I am afraid that I am not prepared to say that we do not discuss anything other than gender dysphoria. It is not just the trials of the drugs; we also have to understand that there are some issues here that are very common to in vitro fertilisation—the most common being that, with in vitro fertilisation, we are increasingly treating patients without any diagnosis of the cause of the infertility. That may be the problem with a trial such as this, and I am sure that the noble Baroness, Lady Cass, will identify and address that problem, because it is a real issue. I suggest that some of the research we are not doing is worth doing but, unfortunately, it is not getting funded. One of the areas that I have already discussed with my noble friend the Minister is epigenetics. Interestingly, there are certain reasons for believing that epigenetics might be very relevant to this situation. I first heard of this when I was lecturing in Melbourne, Australia, in the late 1970s—not that it was called epigenetics then. I came across a consultant who said he had seen so many patients—it was common—who requested gender change or had some form of dysphoria. He said that when he went through the medical records of the obstetric cases, he was interested to find some anomalies. In some cases, patients had been exposed to unusual stress or other issues that might have been related to the environment the mother was in. I have no idea whether that research went on; the consultant is now dead, but I would have loved to have seen it. It was certainly not until about 1999, when Lars Bygren published his first paper on the key issue of what happens to children as they grow up following different exposures to different environments, that we suddenly woke up. These things were often sex-linked, by the way, which is quite interesting. It turns out that some of the issues here are true in transgender as well. That is also a sex-linked issue. Of course, many of these children may have some suggestions of autism or certainly some form of difference or disorder—I do not want to call it mental ill health—that we would not accept as being quite usual: on a spectrum, as is often said. That is a reasonable way of looking at it. I need to explain epigenetics to make this understood. I want noble Lords to consider this question. Let us suppose that “My coat is grey” is written in the alphabet of the DNA. That could be expressed in two ways: “My coat is gray” or “My coat is grey”—the difference between them is not important. It works both ways. But a mutation would be if that “c” was changed into a “g”: “My goat is grey”. I am not suggesting that this is a mutation, but there are other things that we now know affect the DNA and how it works. For example, if you put “My coat is grey” in quotation marks, that changes it. So it is not the actual letters of the DNA but the environment in which it is written. If you put an exclamation mark or a question mark after that sentence, you end up with the possibility of the meaning being totally changed. There is a possibility that that is happening increasingly. We have animal evidence that is very strong, and we also have evidence from Canada—McGill and Toronto—that shows that this might be true in humans and could be to some extent heritable. This is not, of course, gender dysphoria; it is troubles of this sort generally. I do not have an answer to the Question being asked in this debate, but we need to consider how, and whether, we can use drugs for different causes that are not, in fact, a medical condition. The problem is how we define transgender and how we deal with that. That is why I am so pleased that the noble Baroness, Lady Cass, is here to answer those questions, because I think we will want to discuss that at great length. We must have trials if we are going to get anywhere. The problem is: how do we do this without damaging children? I agree completely with the noble Baroness, Lady Deech, that we must do follow-up with transgender. We have not done it at all, and it has to happen.

More from Lord Winston (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.